Why Piper Sandler Thinks UnitedHealth Stock Is the Top Insurer to Buy Now

Group 1 - Piper Sandler analyst Jessica Tassan remains bullish on UnitedHealth (UNH) stock but has lowered her price target from $417 to $396 while maintaining an "Overweight" rating [1][6] - The Centers for Medicare and Medicaid Services (CMS) announced a minimal increase of 0.09% in Medicare Advantage reimbursement rates for 2027, which is insufficient to cover rising health costs [5][6] - UnitedHealth's Medicare and Retirement unit is projected to generate 25% of its revenue in fiscal 2025, indicating significant reliance on Medicare Advantage plans [2][4] Group 2 - UnitedHealth has a market capitalization of $264 billion and a forward price-to-earnings (P/E) ratio of 16.5 times, with third-quarter sales rising 12% year-over-year to $113.2 billion [4] - Despite sales growth, net income decreased to $2.35 billion, and operating cash flow was reported at $5.9 billion, with $27.2 billion in cash and cash equivalents and $72.4 billion in long-term debt as of the end of Q3 [4] - The Medicare Advantage sector faces significant competition, with beneficiaries having access to plans from an average of 8 firms, which may limit UnitedHealth's ability to cut benefits without losing market share [7]